nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Proline—SLC6A7—Amine compound SLC transporters—SLC14A2—urinary bladder cancer	0.0219	0.064	CbGpPWpGaD
L-Proline—PPIG—urine—urinary bladder cancer	0.0213	0.033	CbGeAlD
L-Proline—PPIA—Early Phase of HIV Life Cycle—LIG1—urinary bladder cancer	0.0136	0.0398	CbGpPWpGaD
L-Proline—SLC6A14—Amine compound SLC transporters—SLC14A2—urinary bladder cancer	0.0135	0.0395	CbGpPWpGaD
L-Proline—PPIB—Collagen formation—LOXL4—urinary bladder cancer	0.0121	0.0355	CbGpPWpGaD
L-Proline—PYCR1—Teniposide—Etoposide—urinary bladder cancer	0.0119	1	CbGdCrCtD
L-Proline—P3H2—Collagen formation—LOXL4—urinary bladder cancer	0.0116	0.0339	CbGpPWpGaD
L-Proline—P3H1—Collagen formation—LOXL4—urinary bladder cancer	0.0116	0.0339	CbGpPWpGaD
L-Proline—P3H3—Collagen formation—LOXL4—urinary bladder cancer	0.0116	0.0339	CbGpPWpGaD
L-Proline—PYCRL—prostate gland—urinary bladder cancer	0.0115	0.0178	CbGeAlD
L-Proline—PRODH—prostate gland—urinary bladder cancer	0.0107	0.0165	CbGeAlD
L-Proline—PARS2—prostate gland—urinary bladder cancer	0.01	0.0155	CbGeAlD
L-Proline—L3HYPDH—prostate gland—urinary bladder cancer	0.0095	0.0147	CbGeAlD
L-Proline—EPRS—prostate gland—urinary bladder cancer	0.00931	0.0144	CbGeAlD
L-Proline—PPIB—Collagen formation—LOXL1—urinary bladder cancer	0.00919	0.0269	CbGpPWpGaD
L-Proline—P3H2—Collagen formation—LOXL1—urinary bladder cancer	0.00877	0.0257	CbGpPWpGaD
L-Proline—P3H3—Collagen formation—LOXL1—urinary bladder cancer	0.00877	0.0257	CbGpPWpGaD
L-Proline—P3H1—Collagen formation—LOXL1—urinary bladder cancer	0.00877	0.0257	CbGpPWpGaD
L-Proline—PYCR2—prostate gland—urinary bladder cancer	0.00875	0.0135	CbGeAlD
L-Proline—PPIC—prostate gland—urinary bladder cancer	0.00875	0.0135	CbGeAlD
L-Proline—PYCR1—prostate gland—urinary bladder cancer	0.00867	0.0134	CbGeAlD
L-Proline—SLC6A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.00855	0.025	CbGpPWpGaD
L-Proline—PARS2—seminal vesicle—urinary bladder cancer	0.00849	0.0131	CbGeAlD
L-Proline—PPIH—prostate gland—urinary bladder cancer	0.00841	0.013	CbGeAlD
L-Proline—PRODH—Amino acid and derivative metabolism—GSTZ1—urinary bladder cancer	0.00824	0.0241	CbGpPWpGaD
L-Proline—PROSC—prostate gland—urinary bladder cancer	0.00811	0.0125	CbGeAlD
L-Proline—L3HYPDH—seminal vesicle—urinary bladder cancer	0.00804	0.0124	CbGeAlD
L-Proline—PPIG—prostate gland—urinary bladder cancer	0.00765	0.0118	CbGeAlD
L-Proline—SLC6A14—female reproductive system—urinary bladder cancer	0.0076	0.0118	CbGeAlD
L-Proline—PPIA—prostate gland—urinary bladder cancer	0.00744	0.0115	CbGeAlD
L-Proline—PYCR2—seminal vesicle—urinary bladder cancer	0.0074	0.0114	CbGeAlD
L-Proline—PPIC—seminal vesicle—urinary bladder cancer	0.0074	0.0114	CbGeAlD
L-Proline—P4HA2—prostate gland—urinary bladder cancer	0.00736	0.0114	CbGeAlD
L-Proline—PYCR1—Amino acid and derivative metabolism—GSTZ1—urinary bladder cancer	0.00734	0.0215	CbGpPWpGaD
L-Proline—PYCR1—seminal vesicle—urinary bladder cancer	0.00734	0.0113	CbGeAlD
L-Proline—P3H3—prostate gland—urinary bladder cancer	0.00732	0.0113	CbGeAlD
L-Proline—PRODH—urethra—urinary bladder cancer	0.00716	0.0111	CbGeAlD
L-Proline—PPIH—seminal vesicle—urinary bladder cancer	0.00711	0.011	CbGeAlD
L-Proline—EPRS—Parkinsons Disease Pathway—CCNE1—urinary bladder cancer	0.00697	0.0204	CbGpPWpGaD
L-Proline—PROSC—seminal vesicle—urinary bladder cancer	0.00686	0.0106	CbGeAlD
L-Proline—PARS2—urethra—urinary bladder cancer	0.00672	0.0104	CbGeAlD
L-Proline—EPRS—smooth muscle tissue—urinary bladder cancer	0.0066	0.0102	CbGeAlD
L-Proline—PPIG—seminal vesicle—urinary bladder cancer	0.00647	0.01	CbGeAlD
L-Proline—L3HYPDH—urethra—urinary bladder cancer	0.00636	0.00984	CbGeAlD
L-Proline—P3H1—prostate gland—urinary bladder cancer	0.00625	0.00967	CbGeAlD
L-Proline—PPIC—smooth muscle tissue—urinary bladder cancer	0.00619	0.00958	CbGeAlD
L-Proline—P3H3—seminal vesicle—urinary bladder cancer	0.00619	0.00957	CbGeAlD
L-Proline—PYCR1—smooth muscle tissue—urinary bladder cancer	0.00614	0.0095	CbGeAlD
L-Proline—PPIF—prostate gland—urinary bladder cancer	0.00602	0.00931	CbGeAlD
L-Proline—PPIC—renal system—urinary bladder cancer	0.00596	0.00922	CbGeAlD
L-Proline—PPIH—smooth muscle tissue—urinary bladder cancer	0.00595	0.0092	CbGeAlD
L-Proline—P3H2—prostate gland—urinary bladder cancer	0.00594	0.00919	CbGeAlD
L-Proline—PYCR1—renal system—urinary bladder cancer	0.00591	0.00914	CbGeAlD
L-Proline—PYCR2—urethra—urinary bladder cancer	0.00586	0.00905	CbGeAlD
L-Proline—PPIC—urethra—urinary bladder cancer	0.00586	0.00905	CbGeAlD
L-Proline—PYCR1—urethra—urinary bladder cancer	0.00581	0.00898	CbGeAlD
L-Proline—PPIB—prostate gland—urinary bladder cancer	0.00573	0.00886	CbGeAlD
L-Proline—PYCRL—vagina—urinary bladder cancer	0.0057	0.00881	CbGeAlD
L-Proline—SLC6A7—NRF2 pathway—UGT2B7—urinary bladder cancer	0.00564	0.0165	CbGpPWpGaD
L-Proline—PPIH—urethra—urinary bladder cancer	0.00563	0.0087	CbGeAlD
L-Proline—PPIG—epithelium—urinary bladder cancer	0.00562	0.0087	CbGeAlD
L-Proline—PROSC—renal system—urinary bladder cancer	0.00553	0.00855	CbGeAlD
L-Proline—PARS2—female reproductive system—urinary bladder cancer	0.00548	0.00847	CbGeAlD
L-Proline—PROSC—urethra—urinary bladder cancer	0.00543	0.00839	CbGeAlD
L-Proline—PPIG—smooth muscle tissue—urinary bladder cancer	0.00542	0.00838	CbGeAlD
L-Proline—SLC6A7—Amino acid and derivative metabolism—GSTZ1—urinary bladder cancer	0.00531	0.0156	CbGpPWpGaD
L-Proline—P3H1—seminal vesicle—urinary bladder cancer	0.00529	0.00818	CbGeAlD
L-Proline—PRODH—vagina—urinary bladder cancer	0.00528	0.00817	CbGeAlD
L-Proline—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.00528	0.0155	CbGpPWpGaD
L-Proline—PPIG—renal system—urinary bladder cancer	0.00522	0.00807	CbGeAlD
L-Proline—P4HA2—smooth muscle tissue—urinary bladder cancer	0.00521	0.00805	CbGeAlD
L-Proline—L3HYPDH—female reproductive system—urinary bladder cancer	0.00519	0.00802	CbGeAlD
L-Proline—PPIG—urethra—urinary bladder cancer	0.00512	0.00792	CbGeAlD
L-Proline—PPIF—seminal vesicle—urinary bladder cancer	0.00509	0.00788	CbGeAlD
L-Proline—P3H2—seminal vesicle—urinary bladder cancer	0.00503	0.00778	CbGeAlD
L-Proline—P4HA2—renal system—urinary bladder cancer	0.00501	0.00775	CbGeAlD
L-Proline—PPIA—urethra—urinary bladder cancer	0.00498	0.0077	CbGeAlD
L-Proline—PARS2—vagina—urinary bladder cancer	0.00496	0.00766	CbGeAlD
L-Proline—P3H3—urethra—urinary bladder cancer	0.0049	0.00757	CbGeAlD
L-Proline—PPIB—Extracellular matrix organization—LOXL4—urinary bladder cancer	0.00485	0.0142	CbGpPWpGaD
L-Proline—PPIB—seminal vesicle—urinary bladder cancer	0.00485	0.0075	CbGeAlD
L-Proline—PYCR2—female reproductive system—urinary bladder cancer	0.00477	0.00738	CbGeAlD
L-Proline—PPIC—female reproductive system—urinary bladder cancer	0.00477	0.00738	CbGeAlD
L-Proline—PYCR1—female reproductive system—urinary bladder cancer	0.00473	0.00732	CbGeAlD
L-Proline—P4HA1—prostate gland—urinary bladder cancer	0.00472	0.0073	CbGeAlD
L-Proline—L3HYPDH—vagina—urinary bladder cancer	0.00469	0.00725	CbGeAlD
L-Proline—P3H3—Extracellular matrix organization—LOXL4—urinary bladder cancer	0.00463	0.0136	CbGpPWpGaD
L-Proline—P3H2—Extracellular matrix organization—LOXL4—urinary bladder cancer	0.00463	0.0136	CbGpPWpGaD
L-Proline—P3H1—Extracellular matrix organization—LOXL4—urinary bladder cancer	0.00463	0.0136	CbGpPWpGaD
L-Proline—EPRS—vagina—urinary bladder cancer	0.0046	0.00711	CbGeAlD
L-Proline—PPIH—female reproductive system—urinary bladder cancer	0.00459	0.0071	CbGeAlD
L-Proline—P3H1—smooth muscle tissue—urinary bladder cancer	0.00443	0.00685	CbGeAlD
L-Proline—PROSC—female reproductive system—urinary bladder cancer	0.00443	0.00684	CbGeAlD
L-Proline—PPIC—vagina—urinary bladder cancer	0.00432	0.00668	CbGeAlD
L-Proline—PYCR2—vagina—urinary bladder cancer	0.00432	0.00668	CbGeAlD
L-Proline—PYCR1—vagina—urinary bladder cancer	0.00428	0.00662	CbGeAlD
L-Proline—PPIF—smooth muscle tissue—urinary bladder cancer	0.00426	0.00659	CbGeAlD
L-Proline—PPIB—epithelium—urinary bladder cancer	0.00421	0.00651	CbGeAlD
L-Proline—P3H1—urethra—urinary bladder cancer	0.00419	0.00647	CbGeAlD
L-Proline—PPIG—female reproductive system—urinary bladder cancer	0.00418	0.00646	CbGeAlD
L-Proline—PPIB—Syndecan-1-mediated signaling events—FGFR3—urinary bladder cancer	0.00415	0.0122	CbGpPWpGaD
L-Proline—PPIH—vagina—urinary bladder cancer	0.00415	0.00642	CbGeAlD
L-Proline—PPIF—renal system—urinary bladder cancer	0.0041	0.00635	CbGeAlD
L-Proline—PPIB—smooth muscle tissue—urinary bladder cancer	0.00406	0.00628	CbGeAlD
L-Proline—P3H2—renal system—urinary bladder cancer	0.00405	0.00627	CbGeAlD
L-Proline—PPIF—urethra—urinary bladder cancer	0.00403	0.00623	CbGeAlD
L-Proline—P4HA2—female reproductive system—urinary bladder cancer	0.00401	0.00621	CbGeAlD
L-Proline—PROSC—vagina—urinary bladder cancer	0.004	0.00619	CbGeAlD
L-Proline—P4HA1—seminal vesicle—urinary bladder cancer	0.00399	0.00618	CbGeAlD
L-Proline—P3H3—female reproductive system—urinary bladder cancer	0.00399	0.00618	CbGeAlD
L-Proline—P3H2—urethra—urinary bladder cancer	0.00398	0.00615	CbGeAlD
L-Proline—PPIB—renal system—urinary bladder cancer	0.00391	0.00604	CbGeAlD
L-Proline—SLC6A7—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.00388	0.0114	CbGpPWpGaD
L-Proline—PPIB—urethra—urinary bladder cancer	0.00384	0.00593	CbGeAlD
L-Proline—PPIG—vagina—urinary bladder cancer	0.00378	0.00584	CbGeAlD
L-Proline—PYCRL—lymph node—urinary bladder cancer	0.00368	0.0057	CbGeAlD
L-Proline—PPIB—Extracellular matrix organization—LOXL1—urinary bladder cancer	0.00368	0.0108	CbGpPWpGaD
L-Proline—PPIA—vagina—urinary bladder cancer	0.00367	0.00568	CbGeAlD
L-Proline—P4HA2—vagina—urinary bladder cancer	0.00363	0.00561	CbGeAlD
L-Proline—P3H3—Extracellular matrix organization—LOXL1—urinary bladder cancer	0.00351	0.0103	CbGpPWpGaD
L-Proline—P3H1—Extracellular matrix organization—LOXL1—urinary bladder cancer	0.00351	0.0103	CbGpPWpGaD
L-Proline—P3H2—Extracellular matrix organization—LOXL1—urinary bladder cancer	0.00351	0.0103	CbGpPWpGaD
L-Proline—SLC6A14—NRF2 pathway—UGT2B7—urinary bladder cancer	0.00348	0.0102	CbGpPWpGaD
L-Proline—PRODH—lymph node—urinary bladder cancer	0.00342	0.00528	CbGeAlD
L-Proline—P4HA1—smooth muscle tissue—urinary bladder cancer	0.00334	0.00517	CbGeAlD
L-Proline—PPIF—female reproductive system—urinary bladder cancer	0.00329	0.00508	CbGeAlD
L-Proline—P3H2—female reproductive system—urinary bladder cancer	0.00324	0.00502	CbGeAlD
L-Proline—SLC16A10—prostate gland—urinary bladder cancer	0.00324	0.00501	CbGeAlD
L-Proline—P4HA1—renal system—urinary bladder cancer	0.00322	0.00498	CbGeAlD
L-Proline—PARS2—lymph node—urinary bladder cancer	0.00321	0.00496	CbGeAlD
L-Proline—P4HA1—urethra—urinary bladder cancer	0.00316	0.00489	CbGeAlD
L-Proline—PPIB—female reproductive system—urinary bladder cancer	0.00313	0.00484	CbGeAlD
L-Proline—P3H1—vagina—urinary bladder cancer	0.00309	0.00477	CbGeAlD
L-Proline—L3HYPDH—lymph node—urinary bladder cancer	0.00303	0.00469	CbGeAlD
L-Proline—EPRS—lymph node—urinary bladder cancer	0.00297	0.0046	CbGeAlD
L-Proline—PPIF—vagina—urinary bladder cancer	0.00297	0.0046	CbGeAlD
L-Proline—P3H2—vagina—urinary bladder cancer	0.00293	0.00454	CbGeAlD
L-Proline—PPIB—vagina—urinary bladder cancer	0.00283	0.00438	CbGeAlD
L-Proline—PYCR2—lymph node—urinary bladder cancer	0.00279	0.00432	CbGeAlD
L-Proline—PPIC—lymph node—urinary bladder cancer	0.00279	0.00432	CbGeAlD
L-Proline—PYCR1—lymph node—urinary bladder cancer	0.00277	0.00428	CbGeAlD
L-Proline—PRODH—Amino acid and derivative metabolism—NQO1—urinary bladder cancer	0.00276	0.00808	CbGpPWpGaD
L-Proline—PPIH—lymph node—urinary bladder cancer	0.00268	0.00415	CbGeAlD
L-Proline—PROSC—lymph node—urinary bladder cancer	0.00259	0.004	CbGeAlD
L-Proline—P4HA1—female reproductive system—urinary bladder cancer	0.00258	0.00399	CbGeAlD
L-Proline—PPIB—Syndecan-1-mediated signaling events—MMP9—urinary bladder cancer	0.00254	0.00743	CbGpPWpGaD
L-Proline—PYCR1—Amino acid and derivative metabolism—NQO1—urinary bladder cancer	0.00246	0.0072	CbGpPWpGaD
L-Proline—PPIG—lymph node—urinary bladder cancer	0.00244	0.00378	CbGeAlD
L-Proline—SLC6A14—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.0024	0.00703	CbGpPWpGaD
L-Proline—SLC16A10—epithelium—urinary bladder cancer	0.00238	0.00368	CbGeAlD
L-Proline—PPIA—lymph node—urinary bladder cancer	0.00237	0.00367	CbGeAlD
L-Proline—P4HA2—lymph node—urinary bladder cancer	0.00235	0.00363	CbGeAlD
L-Proline—P3H3—lymph node—urinary bladder cancer	0.00234	0.00361	CbGeAlD
L-Proline—P4HA1—vagina—urinary bladder cancer	0.00233	0.00361	CbGeAlD
L-Proline—PPIA—HIV Life Cycle—LIG1—urinary bladder cancer	0.0022	0.00645	CbGpPWpGaD
L-Proline—SLC6A7—NRF2 pathway—NQO1—urinary bladder cancer	0.00218	0.00637	CbGpPWpGaD
L-Proline—P3H1—lymph node—urinary bladder cancer	0.002	0.00309	CbGeAlD
L-Proline—SLC6A7—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.00197	0.00578	CbGpPWpGaD
L-Proline—PPIF—lymph node—urinary bladder cancer	0.00192	0.00297	CbGeAlD
L-Proline—P3H2—lymph node—urinary bladder cancer	0.0019	0.00294	CbGeAlD
L-Proline—PPIB—lymph node—urinary bladder cancer	0.00183	0.00283	CbGeAlD
L-Proline—SLC6A7—NRF2 pathway—GSTP1—urinary bladder cancer	0.00181	0.00532	CbGpPWpGaD
L-Proline—SLC6A7—Amino acid and derivative metabolism—NQO1—urinary bladder cancer	0.00178	0.00521	CbGpPWpGaD
L-Proline—SLC16A10—female reproductive system—urinary bladder cancer	0.00177	0.00273	CbGeAlD
L-Proline—PPIA—Host Interactions of HIV factors—RBX1—urinary bladder cancer	0.00169	0.00496	CbGpPWpGaD
L-Proline—SLC6A7—NRF2 pathway—GSTM1—urinary bladder cancer	0.00167	0.00488	CbGpPWpGaD
L-Proline—SLC16A10—vagina—urinary bladder cancer	0.0016	0.00247	CbGeAlD
L-Proline—PPIA—HIV Infection—LIG1—urinary bladder cancer	0.00152	0.00445	CbGpPWpGaD
L-Proline—PRODH—Metabolism—GSTZ1—urinary bladder cancer	0.00151	0.00443	CbGpPWpGaD
L-Proline—P4HA1—lymph node—urinary bladder cancer	0.00151	0.00233	CbGeAlD
L-Proline—PRODH—Metabolism—GSTO2—urinary bladder cancer	0.00143	0.0042	CbGpPWpGaD
L-Proline—PRODH—Metabolism—NAT1—urinary bladder cancer	0.00143	0.0042	CbGpPWpGaD
L-Proline—SLC6A7—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.00143	0.00418	CbGpPWpGaD
L-Proline—SLC16A10—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.00136	0.00397	CbGpPWpGaD
L-Proline—PYCR1—Metabolism—GSTZ1—urinary bladder cancer	0.00135	0.00395	CbGpPWpGaD
L-Proline—PPIB—Collagen formation—MMP9—urinary bladder cancer	0.00135	0.00394	CbGpPWpGaD
L-Proline—SLC6A14—NRF2 pathway—NQO1—urinary bladder cancer	0.00134	0.00394	CbGpPWpGaD
L-Proline—PRODH—Metabolism—UGT2B7—urinary bladder cancer	0.00131	0.00384	CbGpPWpGaD
L-Proline—P3H1—Collagen formation—MMP9—urinary bladder cancer	0.00128	0.00376	CbGpPWpGaD
L-Proline—P3H2—Collagen formation—MMP9—urinary bladder cancer	0.00128	0.00376	CbGpPWpGaD
L-Proline—P3H3—Collagen formation—MMP9—urinary bladder cancer	0.00128	0.00376	CbGpPWpGaD
L-Proline—PYCR1—Metabolism—GSTO2—urinary bladder cancer	0.00128	0.00375	CbGpPWpGaD
L-Proline—PYCR1—Metabolism—NAT1—urinary bladder cancer	0.00128	0.00375	CbGpPWpGaD
L-Proline—SLC6A14—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.00122	0.00357	CbGpPWpGaD
L-Proline—PRODH—Metabolism—CYP4B1—urinary bladder cancer	0.00118	0.00346	CbGpPWpGaD
L-Proline—PYCR1—Metabolism—UGT2B7—urinary bladder cancer	0.00117	0.00343	CbGpPWpGaD
L-Proline—SLC6A7—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.00116	0.00341	CbGpPWpGaD
L-Proline—SLC6A14—NRF2 pathway—GSTP1—urinary bladder cancer	0.00112	0.00328	CbGpPWpGaD
L-Proline—PRODH—Metabolism—SLC19A1—urinary bladder cancer	0.00112	0.00327	CbGpPWpGaD
L-Proline—PPIA—HIV Infection—RBX1—urinary bladder cancer	0.0011	0.00322	CbGpPWpGaD
L-Proline—PRODH—Metabolism—PRSS3—urinary bladder cancer	0.00109	0.00318	CbGpPWpGaD
L-Proline—PPIA—Platelet degranulation—IGF1—urinary bladder cancer	0.00108	0.00316	CbGpPWpGaD
L-Proline—PPIA—Late Phase of HIV Life Cycle—ERCC2—urinary bladder cancer	0.00106	0.0031	CbGpPWpGaD
L-Proline—PYCR1—Metabolism—CYP4B1—urinary bladder cancer	0.00105	0.00308	CbGpPWpGaD
L-Proline—SLC16A10—lymph node—urinary bladder cancer	0.00103	0.0016	CbGeAlD
L-Proline—SLC6A14—NRF2 pathway—GSTM1—urinary bladder cancer	0.00103	0.00302	CbGpPWpGaD
L-Proline—PPIA—Response to elevated platelet cytosolic Ca2+—IGF1—urinary bladder cancer	0.00103	0.00301	CbGpPWpGaD
L-Proline—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	0.00101	0.00295	CbGpPWpGaD
L-Proline—PYCR1—Metabolism—SLC19A1—urinary bladder cancer	0.000994	0.00291	CbGpPWpGaD
L-Proline—PPIA—HIV Life Cycle—ERCC2—urinary bladder cancer	0.000975	0.00286	CbGpPWpGaD
L-Proline—SLC6A7—Metabolism—GSTZ1—urinary bladder cancer	0.000975	0.00286	CbGpPWpGaD
L-Proline—PYCR1—Metabolism—PRSS3—urinary bladder cancer	0.000969	0.00284	CbGpPWpGaD
L-Proline—SLC6A7—Metabolism—GSTO2—urinary bladder cancer	0.000924	0.00271	CbGpPWpGaD
L-Proline—SLC6A7—Metabolism—NAT1—urinary bladder cancer	0.000924	0.00271	CbGpPWpGaD
L-Proline—SLC6A14—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000882	0.00258	CbGpPWpGaD
L-Proline—PRODH—Metabolism—TYMP—urinary bladder cancer	0.000869	0.00255	CbGpPWpGaD
L-Proline—SLC6A7—Metabolism—UGT2B7—urinary bladder cancer	0.000845	0.00248	CbGpPWpGaD
L-Proline—PRODH—Metabolism—NAT2—urinary bladder cancer	0.000786	0.0023	CbGpPWpGaD
L-Proline—SLC6A7—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000786	0.0023	CbGpPWpGaD
L-Proline—PYCR1—Metabolism—TYMP—urinary bladder cancer	0.000775	0.00227	CbGpPWpGaD
L-Proline—SLC6A7—Metabolism—CYP4B1—urinary bladder cancer	0.000761	0.00223	CbGpPWpGaD
L-Proline—PPIB—Extracellular matrix organization—CDH1—urinary bladder cancer	0.000744	0.00218	CbGpPWpGaD
L-Proline—PARS2—Gene Expression—SMC1A—urinary bladder cancer	0.000742	0.00217	CbGpPWpGaD
L-Proline—SLC6A7—Metabolism—SLC19A1—urinary bladder cancer	0.000719	0.00211	CbGpPWpGaD
L-Proline—SLC6A14—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000719	0.0021	CbGpPWpGaD
L-Proline—P3H1—Extracellular matrix organization—CDH1—urinary bladder cancer	0.000709	0.00208	CbGpPWpGaD
L-Proline—P3H3—Extracellular matrix organization—CDH1—urinary bladder cancer	0.000709	0.00208	CbGpPWpGaD
L-Proline—P3H2—Extracellular matrix organization—CDH1—urinary bladder cancer	0.000709	0.00208	CbGpPWpGaD
L-Proline—SLC6A7—Metabolism—PRSS3—urinary bladder cancer	0.000701	0.00205	CbGpPWpGaD
L-Proline—PYCR1—Metabolism—NAT2—urinary bladder cancer	0.000701	0.00205	CbGpPWpGaD
L-Proline—SLC16A10—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000689	0.00202	CbGpPWpGaD
L-Proline—PRODH—Metabolism—RRM2—urinary bladder cancer	0.000678	0.00199	CbGpPWpGaD
L-Proline—PPIA—HIV Infection—ERCC2—urinary bladder cancer	0.000674	0.00197	CbGpPWpGaD
L-Proline—EPRS—Gene Expression—SMC1A—urinary bladder cancer	0.000661	0.00194	CbGpPWpGaD
L-Proline—PPIA—Disease—GSTO2—urinary bladder cancer	0.000649	0.0019	CbGpPWpGaD
L-Proline—PARS2—Gene Expression—ESR2—urinary bladder cancer	0.000647	0.00189	CbGpPWpGaD
L-Proline—PRODH—Metabolism—HPGDS—urinary bladder cancer	0.000628	0.00184	CbGpPWpGaD
L-Proline—PRODH—Metabolism—ENO2—urinary bladder cancer	0.000628	0.00184	CbGpPWpGaD
L-Proline—PPIA—Cell surface interactions at the vascular wall—SRC—urinary bladder cancer	0.00061	0.00179	CbGpPWpGaD
L-Proline—PRODH—Metabolism—GSTT1—urinary bladder cancer	0.000609	0.00179	CbGpPWpGaD
L-Proline—PYCR1—Metabolism—RRM2—urinary bladder cancer	0.000605	0.00177	CbGpPWpGaD
L-Proline—EPRS—Gene Expression—ESR2—urinary bladder cancer	0.000576	0.00169	CbGpPWpGaD
L-Proline—SLC6A7—Metabolism—TYMP—urinary bladder cancer	0.00056	0.00164	CbGpPWpGaD
L-Proline—PYCR1—Metabolism—ENO2—urinary bladder cancer	0.00056	0.00164	CbGpPWpGaD
L-Proline—PYCR1—Metabolism—HPGDS—urinary bladder cancer	0.00056	0.00164	CbGpPWpGaD
L-Proline—PYCR1—Metabolism—GSTT1—urinary bladder cancer	0.000543	0.00159	CbGpPWpGaD
L-Proline—PPIB—Extracellular matrix organization—MMP9—urinary bladder cancer	0.000538	0.00158	CbGpPWpGaD
L-Proline—P3H1—Extracellular matrix organization—MMP9—urinary bladder cancer	0.000513	0.0015	CbGpPWpGaD
L-Proline—P3H2—Extracellular matrix organization—MMP9—urinary bladder cancer	0.000513	0.0015	CbGpPWpGaD
L-Proline—P3H3—Extracellular matrix organization—MMP9—urinary bladder cancer	0.000513	0.0015	CbGpPWpGaD
L-Proline—PRODH—Metabolism—NQO1—urinary bladder cancer	0.000506	0.00148	CbGpPWpGaD
L-Proline—SLC6A7—Metabolism—NAT2—urinary bladder cancer	0.000506	0.00148	CbGpPWpGaD
L-Proline—PPIA—Cell surface interactions at the vascular wall—KRAS—urinary bladder cancer	0.000505	0.00148	CbGpPWpGaD
L-Proline—PPIA—Disease—SLC19A1—urinary bladder cancer	0.000504	0.00148	CbGpPWpGaD
L-Proline—PARS2—Gene Expression—NCOR1—urinary bladder cancer	0.000499	0.00146	CbGpPWpGaD
L-Proline—SLC16A10—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000498	0.00146	CbGpPWpGaD
L-Proline—PPIA—Disease—PRSS3—urinary bladder cancer	0.000492	0.00144	CbGpPWpGaD
L-Proline—SLC6A14—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000485	0.00142	CbGpPWpGaD
L-Proline—PPIA—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	0.000478	0.0014	CbGpPWpGaD
L-Proline—PARS2—Gene Expression—ERCC2—urinary bladder cancer	0.000469	0.00137	CbGpPWpGaD
L-Proline—PPIA—Disease—HDAC4—urinary bladder cancer	0.000469	0.00137	CbGpPWpGaD
L-Proline—PYCR1—Metabolism—NQO1—urinary bladder cancer	0.000451	0.00132	CbGpPWpGaD
L-Proline—EPRS—Gene Expression—NCOR1—urinary bladder cancer	0.000445	0.0013	CbGpPWpGaD
L-Proline—PPIA—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	0.000438	0.00128	CbGpPWpGaD
L-Proline—SLC6A7—Metabolism—RRM2—urinary bladder cancer	0.000437	0.00128	CbGpPWpGaD
L-Proline—PPIA—Cell surface interactions at the vascular wall—HRAS—urinary bladder cancer	0.000429	0.00126	CbGpPWpGaD
L-Proline—PPIA—Hemostasis—IFNA2—urinary bladder cancer	0.000426	0.00125	CbGpPWpGaD
L-Proline—PRODH—Metabolism—GSTP1—urinary bladder cancer	0.000422	0.00124	CbGpPWpGaD
L-Proline—EPRS—Gene Expression—ERCC2—urinary bladder cancer	0.000418	0.00123	CbGpPWpGaD
L-Proline—SLC16A10—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000406	0.00119	CbGpPWpGaD
L-Proline—SLC6A7—Metabolism—ENO2—urinary bladder cancer	0.000405	0.00119	CbGpPWpGaD
L-Proline—SLC6A7—Metabolism—HPGDS—urinary bladder cancer	0.000405	0.00119	CbGpPWpGaD
L-Proline—SLC6A7—Metabolism—GSTT1—urinary bladder cancer	0.000393	0.00115	CbGpPWpGaD
L-Proline—PRODH—Metabolism—TYMS—urinary bladder cancer	0.000393	0.00115	CbGpPWpGaD
L-Proline—PARS2—Gene Expression—ESR1—urinary bladder cancer	0.000392	0.00115	CbGpPWpGaD
L-Proline—PRODH—Metabolism—NCOR1—urinary bladder cancer	0.000388	0.00114	CbGpPWpGaD
L-Proline—PRODH—Metabolism—GSTM1—urinary bladder cancer	0.000388	0.00114	CbGpPWpGaD
L-Proline—PYCR1—Metabolism—GSTP1—urinary bladder cancer	0.000377	0.0011	CbGpPWpGaD
L-Proline—PPIA—Disease—LIG1—urinary bladder cancer	0.000373	0.00109	CbGpPWpGaD
L-Proline—PRODH—Metabolism—GPX1—urinary bladder cancer	0.000372	0.00109	CbGpPWpGaD
L-Proline—SLC6A7—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000368	0.00108	CbGpPWpGaD
L-Proline—PPIA—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	0.000368	0.00108	CbGpPWpGaD
L-Proline—PRODH—Metabolism—ERCC2—urinary bladder cancer	0.000365	0.00107	CbGpPWpGaD
L-Proline—PARS2—Gene Expression—PPARG—urinary bladder cancer	0.000358	0.00105	CbGpPWpGaD
L-Proline—PYCR1—Metabolism—TYMS—urinary bladder cancer	0.00035	0.00103	CbGpPWpGaD
L-Proline—EPRS—Gene Expression—ESR1—urinary bladder cancer	0.00035	0.00102	CbGpPWpGaD
L-Proline—PYCR1—Metabolism—NCOR1—urinary bladder cancer	0.000346	0.00101	CbGpPWpGaD
L-Proline—PYCR1—Metabolism—GSTM1—urinary bladder cancer	0.000346	0.00101	CbGpPWpGaD
L-Proline—PARS2—Gene Expression—CREBBP—urinary bladder cancer	0.000344	0.00101	CbGpPWpGaD
L-Proline—PRODH—Metabolism—MTHFR—urinary bladder cancer	0.000343	0.001	CbGpPWpGaD
L-Proline—PYCR1—Metabolism—GPX1—urinary bladder cancer	0.000331	0.000971	CbGpPWpGaD
L-Proline—SLC6A7—Metabolism—NQO1—urinary bladder cancer	0.000326	0.000956	CbGpPWpGaD
L-Proline—PYCR1—Metabolism—ERCC2—urinary bladder cancer	0.000325	0.000953	CbGpPWpGaD
L-Proline—PPIA—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	0.000321	0.000939	CbGpPWpGaD
L-Proline—EPRS—Gene Expression—PPARG—urinary bladder cancer	0.000319	0.000934	CbGpPWpGaD
L-Proline—EPRS—Gene Expression—CREBBP—urinary bladder cancer	0.000306	0.000897	CbGpPWpGaD
L-Proline—PYCR1—Metabolism—MTHFR—urinary bladder cancer	0.000306	0.000896	CbGpPWpGaD
L-Proline—PPIA—Hemostasis—PLAU—urinary bladder cancer	0.000303	0.000886	CbGpPWpGaD
L-Proline—PPIA—Disease—ENO2—urinary bladder cancer	0.000284	0.000832	CbGpPWpGaD
L-Proline—PRODH—Metabolism—PPARG—urinary bladder cancer	0.000278	0.000815	CbGpPWpGaD
L-Proline—SLC16A10—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000274	0.000803	CbGpPWpGaD
L-Proline—SLC6A7—Metabolism—GSTP1—urinary bladder cancer	0.000272	0.000797	CbGpPWpGaD
L-Proline—PPIA—Disease—RBX1—urinary bladder cancer	0.000269	0.000789	CbGpPWpGaD
L-Proline—PRODH—Metabolism—CREBBP—urinary bladder cancer	0.000267	0.000783	CbGpPWpGaD
L-Proline—SLC6A7—Metabolism—TYMS—urinary bladder cancer	0.000253	0.000741	CbGpPWpGaD
L-Proline—SLC6A7—Metabolism—NCOR1—urinary bladder cancer	0.00025	0.000733	CbGpPWpGaD
L-Proline—SLC6A7—Metabolism—GSTM1—urinary bladder cancer	0.00025	0.000733	CbGpPWpGaD
L-Proline—PPIA—Hemostasis—CREBBP—urinary bladder cancer	0.00025	0.000731	CbGpPWpGaD
L-Proline—PYCR1—Metabolism—PPARG—urinary bladder cancer	0.000248	0.000726	CbGpPWpGaD
L-Proline—PPIA—Hemostasis—IGF1—urinary bladder cancer	0.000246	0.000722	CbGpPWpGaD
L-Proline—PPIA—Disease—JAG1—urinary bladder cancer	0.000241	0.000706	CbGpPWpGaD
L-Proline—SLC6A7—Metabolism—GPX1—urinary bladder cancer	0.00024	0.000702	CbGpPWpGaD
L-Proline—PYCR1—Metabolism—CREBBP—urinary bladder cancer	0.000238	0.000698	CbGpPWpGaD
L-Proline—SLC6A7—Metabolism—ERCC2—urinary bladder cancer	0.000235	0.000689	CbGpPWpGaD
L-Proline—SLC6A14—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000227	0.000665	CbGpPWpGaD
L-Proline—PPIA—Hemostasis—RHOA—urinary bladder cancer	0.000226	0.000661	CbGpPWpGaD
L-Proline—SLC6A7—Metabolism—MTHFR—urinary bladder cancer	0.000221	0.000648	CbGpPWpGaD
L-Proline—PRODH—Metabolism—PTGS2—urinary bladder cancer	0.000219	0.000641	CbGpPWpGaD
L-Proline—PARS2—Gene Expression—MYC—urinary bladder cancer	0.000204	0.000597	CbGpPWpGaD
L-Proline—PYCR1—Metabolism—PTGS2—urinary bladder cancer	0.000195	0.000571	CbGpPWpGaD
L-Proline—PRODH—Metabolism—PTEN—urinary bladder cancer	0.000191	0.000559	CbGpPWpGaD
L-Proline—PPIA—Hemostasis—IL2—urinary bladder cancer	0.000189	0.000555	CbGpPWpGaD
L-Proline—PRODH—Metabolism—EP300—urinary bladder cancer	0.000182	0.000533	CbGpPWpGaD
L-Proline—EPRS—Gene Expression—MYC—urinary bladder cancer	0.000182	0.000533	CbGpPWpGaD
L-Proline—SLC6A7—Metabolism—PPARG—urinary bladder cancer	0.000179	0.000525	CbGpPWpGaD
L-Proline—PPIA—Disease—NCOR1—urinary bladder cancer	0.000176	0.000514	CbGpPWpGaD
L-Proline—SLC6A7—Metabolism—CREBBP—urinary bladder cancer	0.000172	0.000504	CbGpPWpGaD
L-Proline—PYCR1—Metabolism—PTEN—urinary bladder cancer	0.00017	0.000498	CbGpPWpGaD
L-Proline—PPIA—Hemostasis—EP300—urinary bladder cancer	0.00017	0.000498	CbGpPWpGaD
L-Proline—PPIA—Hemostasis—SRC—urinary bladder cancer	0.000165	0.000484	CbGpPWpGaD
L-Proline—PPIA—Disease—ERCC2—urinary bladder cancer	0.000165	0.000483	CbGpPWpGaD
L-Proline—PYCR1—Metabolism—EP300—urinary bladder cancer	0.000162	0.000475	CbGpPWpGaD
L-Proline—PPIA—Disease—MTHFR—urinary bladder cancer	0.000155	0.000454	CbGpPWpGaD
L-Proline—PPIA—Disease—TERT—urinary bladder cancer	0.000155	0.000453	CbGpPWpGaD
L-Proline—PPIA—Disease—FGFR3—urinary bladder cancer	0.000142	0.000416	CbGpPWpGaD
L-Proline—SLC6A7—Metabolism—PTGS2—urinary bladder cancer	0.000141	0.000413	CbGpPWpGaD
L-Proline—PPIA—Hemostasis—KRAS—urinary bladder cancer	0.000137	0.000401	CbGpPWpGaD
L-Proline—SLC16A10—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000128	0.000376	CbGpPWpGaD
L-Proline—SLC6A7—Metabolism—PTEN—urinary bladder cancer	0.000123	0.00036	CbGpPWpGaD
L-Proline—PPIA—Hemostasis—TP53—urinary bladder cancer	0.000122	0.000356	CbGpPWpGaD
L-Proline—PPIA—Disease—CREBBP—urinary bladder cancer	0.000121	0.000354	CbGpPWpGaD
L-Proline—SLC6A7—Metabolism—EP300—urinary bladder cancer	0.000117	0.000344	CbGpPWpGaD
L-Proline—PPIA—Hemostasis—HRAS—urinary bladder cancer	0.000116	0.000341	CbGpPWpGaD
L-Proline—PPIA—Disease—RHOA—urinary bladder cancer	0.000109	0.00032	CbGpPWpGaD
L-Proline—PPIA—Disease—ERBB2—urinary bladder cancer	0.000101	0.000296	CbGpPWpGaD
L-Proline—PPIA—Disease—PTGS2—urinary bladder cancer	9.9e-05	0.00029	CbGpPWpGaD
L-Proline—PPIA—Disease—CDKN1A—urinary bladder cancer	8.65e-05	0.000253	CbGpPWpGaD
L-Proline—PPIA—Disease—PTEN—urinary bladder cancer	8.63e-05	0.000253	CbGpPWpGaD
L-Proline—PPIA—Disease—EP300—urinary bladder cancer	8.23e-05	0.000241	CbGpPWpGaD
L-Proline—PPIA—Disease—SRC—urinary bladder cancer	8e-05	0.000234	CbGpPWpGaD
L-Proline—PPIA—Disease—MYC—urinary bladder cancer	7.17e-05	0.00021	CbGpPWpGaD
L-Proline—PPIA—Disease—EGFR—urinary bladder cancer	7.01e-05	0.000205	CbGpPWpGaD
L-Proline—PPIA—Disease—KRAS—urinary bladder cancer	6.63e-05	0.000194	CbGpPWpGaD
L-Proline—PPIA—Disease—HRAS—urinary bladder cancer	5.63e-05	0.000165	CbGpPWpGaD
